nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—CYP3A4—bone cancer	0.807	1	CbGaD
Azithromycin—Josamycin—CYP3A4—bone cancer	0.00244	0.308	CrCbGaD
Azithromycin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00188	0.0963	CbGpPWpGaD
Azithromycin—Roxithromycin—CYP3A4—bone cancer	0.00132	0.166	CrCbGaD
Azithromycin—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0013	0.0666	CbGpPWpGaD
Azithromycin—Telithromycin—CYP3A4—bone cancer	0.00128	0.162	CrCbGaD
Azithromycin—Troleandomycin—CYP3A4—bone cancer	0.00101	0.128	CrCbGaD
Azithromycin—Clarithromycin—CYP3A4—bone cancer	0.000999	0.126	CrCbGaD
Azithromycin—Erythromycin—CYP3A4—bone cancer	0.000879	0.111	CrCbGaD
Azithromycin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000779	0.0398	CbGpPWpGaD
Azithromycin—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000751	0.0384	CbGpPWpGaD
Azithromycin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000729	0.0373	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000728	0.0372	CbGpPWpGaD
Azithromycin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000692	0.0354	CbGpPWpGaD
Azithromycin—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.000629	0.0321	CbGpPWpGaD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000619	0.0316	CbGpPWpGaD
Azithromycin—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000605	0.0309	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.000497	0.0254	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000478	0.0244	CbGpPWpGaD
Azithromycin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000449	0.023	CbGpPWpGaD
Azithromycin—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000432	0.0221	CbGpPWpGaD
Azithromycin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000426	0.0218	CbGpPWpGaD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000419	0.0214	CbGpPWpGaD
Azithromycin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000378	0.00229	CcSEcCtD
Azithromycin—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000378	0.00229	CcSEcCtD
Azithromycin—Hypotension—Cisplatin—bone cancer	0.000375	0.00227	CcSEcCtD
Azithromycin—Nasopharyngitis—Epirubicin—bone cancer	0.000375	0.00227	CcSEcCtD
Azithromycin—Face oedema—Doxorubicin—bone cancer	0.000375	0.00227	CcSEcCtD
Azithromycin—Gastritis—Epirubicin—bone cancer	0.000371	0.00225	CcSEcCtD
Azithromycin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00037	0.00224	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000366	0.00222	CcSEcCtD
Azithromycin—Asthma—Epirubicin—bone cancer	0.000363	0.0022	CcSEcCtD
Azithromycin—Influenza—Epirubicin—bone cancer	0.000363	0.0022	CcSEcCtD
Azithromycin—Neutropenia—Methotrexate—bone cancer	0.000362	0.00219	CcSEcCtD
Azithromycin—Dysuria—Methotrexate—bone cancer	0.000362	0.00219	CcSEcCtD
Azithromycin—Dehydration—Doxorubicin—bone cancer	0.000361	0.00219	CcSEcCtD
Azithromycin—Paraesthesia—Cisplatin—bone cancer	0.000361	0.00218	CcSEcCtD
Azithromycin—Eosinophilia—Epirubicin—bone cancer	0.000359	0.00217	CcSEcCtD
Azithromycin—Liver function test abnormal—Doxorubicin—bone cancer	0.000358	0.00217	CcSEcCtD
Azithromycin—Dyspnoea—Cisplatin—bone cancer	0.000358	0.00217	CcSEcCtD
Azithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000357	0.0182	CbGpPWpGaD
Azithromycin—Pancreatitis—Epirubicin—bone cancer	0.000356	0.00215	CcSEcCtD
Azithromycin—Abdominal pain upper—Doxorubicin—bone cancer	0.000355	0.00215	CcSEcCtD
Azithromycin—Photosensitivity reaction—Methotrexate—bone cancer	0.000354	0.00214	CcSEcCtD
Azithromycin—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00035	0.00212	CcSEcCtD
Azithromycin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00035	0.00212	CcSEcCtD
Azithromycin—Decreased appetite—Cisplatin—bone cancer	0.000349	0.00211	CcSEcCtD
Azithromycin—Pneumonia—Methotrexate—bone cancer	0.000347	0.0021	CcSEcCtD
Azithromycin—Nasopharyngitis—Doxorubicin—bone cancer	0.000347	0.0021	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000347	0.0021	CcSEcCtD
Azithromycin—Infestation—Methotrexate—bone cancer	0.000345	0.00209	CcSEcCtD
Azithromycin—Infestation NOS—Methotrexate—bone cancer	0.000345	0.00209	CcSEcCtD
Azithromycin—Gastritis—Doxorubicin—bone cancer	0.000344	0.00208	CcSEcCtD
Azithromycin—Pain—Cisplatin—bone cancer	0.000343	0.00208	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000343	0.00207	CcSEcCtD
Azithromycin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000342	0.00207	CcSEcCtD
Azithromycin—Neutropenia—Epirubicin—bone cancer	0.000339	0.00205	CcSEcCtD
Azithromycin—Dysuria—Epirubicin—bone cancer	0.000339	0.00205	CcSEcCtD
Azithromycin—Stomatitis—Methotrexate—bone cancer	0.000337	0.00204	CcSEcCtD
Azithromycin—Asthma—Doxorubicin—bone cancer	0.000336	0.00203	CcSEcCtD
Azithromycin—Influenza—Doxorubicin—bone cancer	0.000336	0.00203	CcSEcCtD
Azithromycin—Pollakiuria—Epirubicin—bone cancer	0.000335	0.00203	CcSEcCtD
Azithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000334	0.0171	CbGpPWpGaD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000333	0.017	CbGpPWpGaD
Azithromycin—Eosinophilia—Doxorubicin—bone cancer	0.000332	0.00201	CcSEcCtD
Azithromycin—Sweating—Methotrexate—bone cancer	0.000331	0.00201	CcSEcCtD
Azithromycin—Photosensitivity reaction—Epirubicin—bone cancer	0.000331	0.002	CcSEcCtD
Azithromycin—Feeling abnormal—Cisplatin—bone cancer	0.000331	0.002	CcSEcCtD
Azithromycin—Pancreatitis—Doxorubicin—bone cancer	0.000329	0.00199	CcSEcCtD
Azithromycin—Pneumonia—Epirubicin—bone cancer	0.000325	0.00197	CcSEcCtD
Azithromycin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000325	0.0166	CbGpPWpGaD
Azithromycin—Infestation—Epirubicin—bone cancer	0.000323	0.00196	CcSEcCtD
Azithromycin—Infestation NOS—Epirubicin—bone cancer	0.000323	0.00196	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000321	0.00194	CcSEcCtD
Azithromycin—Body temperature increased—Cisplatin—bone cancer	0.000317	0.00192	CcSEcCtD
Azithromycin—Stomatitis—Epirubicin—bone cancer	0.000315	0.00191	CcSEcCtD
Azithromycin—Jaundice—Epirubicin—bone cancer	0.000315	0.00191	CcSEcCtD
Azithromycin—Dysuria—Doxorubicin—bone cancer	0.000314	0.0019	CcSEcCtD
Azithromycin—Neutropenia—Doxorubicin—bone cancer	0.000314	0.0019	CcSEcCtD
Azithromycin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000311	0.0159	CbGpPWpGaD
Azithromycin—Hepatitis—Methotrexate—bone cancer	0.00031	0.00188	CcSEcCtD
Azithromycin—Sweating—Epirubicin—bone cancer	0.00031	0.00188	CcSEcCtD
Azithromycin—Pollakiuria—Doxorubicin—bone cancer	0.00031	0.00188	CcSEcCtD
Azithromycin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000306	0.00185	CcSEcCtD
Azithromycin—Sinusitis—Epirubicin—bone cancer	0.000303	0.00184	CcSEcCtD
Azithromycin—Pneumonia—Doxorubicin—bone cancer	0.000301	0.00182	CcSEcCtD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.0003	0.0153	CbGpPWpGaD
Azithromycin—Infestation—Doxorubicin—bone cancer	0.000299	0.00181	CcSEcCtD
Azithromycin—Infestation NOS—Doxorubicin—bone cancer	0.000299	0.00181	CcSEcCtD
Azithromycin—Visual impairment—Methotrexate—bone cancer	0.000299	0.00181	CcSEcCtD
Azithromycin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000299	0.0153	CbGpPWpGaD
Azithromycin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000297	0.0018	CcSEcCtD
Azithromycin—Hypersensitivity—Cisplatin—bone cancer	0.000296	0.00179	CcSEcCtD
Azithromycin—Erythema multiforme—Methotrexate—bone cancer	0.000293	0.00178	CcSEcCtD
Azithromycin—Stomatitis—Doxorubicin—bone cancer	0.000292	0.00177	CcSEcCtD
Azithromycin—Jaundice—Doxorubicin—bone cancer	0.000292	0.00177	CcSEcCtD
Azithromycin—Rhinitis—Epirubicin—bone cancer	0.000291	0.00176	CcSEcCtD
Azithromycin—Hepatitis—Epirubicin—bone cancer	0.00029	0.00176	CcSEcCtD
Azithromycin—Tinnitus—Methotrexate—bone cancer	0.000289	0.00175	CcSEcCtD
Azithromycin—Hypoaesthesia—Epirubicin—bone cancer	0.000289	0.00175	CcSEcCtD
Azithromycin—Asthenia—Cisplatin—bone cancer	0.000288	0.00174	CcSEcCtD
Azithromycin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000287	0.0147	CbGpPWpGaD
Azithromycin—Sweating—Doxorubicin—bone cancer	0.000287	0.00174	CcSEcCtD
Azithromycin—Sinusitis—Doxorubicin—bone cancer	0.000281	0.0017	CcSEcCtD
Azithromycin—Visual impairment—Epirubicin—bone cancer	0.00028	0.00169	CcSEcCtD
Azithromycin—Chills—Methotrexate—bone cancer	0.000278	0.00169	CcSEcCtD
Azithromycin—Diarrhoea—Cisplatin—bone cancer	0.000275	0.00166	CcSEcCtD
Azithromycin—Erythema multiforme—Epirubicin—bone cancer	0.000274	0.00166	CcSEcCtD
Azithromycin—Tinnitus—Epirubicin—bone cancer	0.000271	0.00164	CcSEcCtD
Azithromycin—Rhinitis—Doxorubicin—bone cancer	0.000269	0.00163	CcSEcCtD
Azithromycin—Hepatitis—Doxorubicin—bone cancer	0.000269	0.00163	CcSEcCtD
Azithromycin—Hypoaesthesia—Doxorubicin—bone cancer	0.000267	0.00162	CcSEcCtD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000266	0.0136	CbGpPWpGaD
Azithromycin—Dysgeusia—Methotrexate—bone cancer	0.000264	0.0016	CcSEcCtD
Azithromycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000261	0.0133	CbGpPWpGaD
Azithromycin—Chills—Epirubicin—bone cancer	0.00026	0.00158	CcSEcCtD
Azithromycin—Arrhythmia—Epirubicin—bone cancer	0.000259	0.00157	CcSEcCtD
Azithromycin—Visual impairment—Doxorubicin—bone cancer	0.000259	0.00157	CcSEcCtD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000258	0.0132	CbGpPWpGaD
Azithromycin—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000258	0.0132	CbGpPWpGaD
Azithromycin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000257	0.0131	CbGpPWpGaD
Azithromycin—Vomiting—Cisplatin—bone cancer	0.000255	0.00155	CcSEcCtD
Azithromycin—Vision blurred—Methotrexate—bone cancer	0.000254	0.00154	CcSEcCtD
Azithromycin—Erythema multiforme—Doxorubicin—bone cancer	0.000254	0.00154	CcSEcCtD
Azithromycin—Rash—Cisplatin—bone cancer	0.000253	0.00153	CcSEcCtD
Azithromycin—Dermatitis—Cisplatin—bone cancer	0.000253	0.00153	CcSEcCtD
Azithromycin—Ill-defined disorder—Methotrexate—bone cancer	0.00025	0.00152	CcSEcCtD
Azithromycin—Tinnitus—Doxorubicin—bone cancer	0.00025	0.00152	CcSEcCtD
Azithromycin—Anaemia—Methotrexate—bone cancer	0.00025	0.00151	CcSEcCtD
Azithromycin—Flatulence—Epirubicin—bone cancer	0.000249	0.00151	CcSEcCtD
Azithromycin—Tension—Epirubicin—bone cancer	0.000248	0.0015	CcSEcCtD
Azithromycin—Dysgeusia—Epirubicin—bone cancer	0.000247	0.0015	CcSEcCtD
Azithromycin—Nervousness—Epirubicin—bone cancer	0.000245	0.00149	CcSEcCtD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000245	0.0125	CbGpPWpGaD
Azithromycin—Malaise—Methotrexate—bone cancer	0.000243	0.00147	CcSEcCtD
Azithromycin—Vertigo—Methotrexate—bone cancer	0.000243	0.00147	CcSEcCtD
Azithromycin—Leukopenia—Methotrexate—bone cancer	0.000242	0.00146	CcSEcCtD
Azithromycin—Chills—Doxorubicin—bone cancer	0.000241	0.00146	CcSEcCtD
Azithromycin—Arrhythmia—Doxorubicin—bone cancer	0.00024	0.00145	CcSEcCtD
Azithromycin—Nausea—Cisplatin—bone cancer	0.000239	0.00144	CcSEcCtD
Azithromycin—Vision blurred—Epirubicin—bone cancer	0.000238	0.00144	CcSEcCtD
Azithromycin—Cough—Methotrexate—bone cancer	0.000236	0.00143	CcSEcCtD
Azithromycin—Ill-defined disorder—Epirubicin—bone cancer	0.000234	0.00142	CcSEcCtD
Azithromycin—Convulsion—Methotrexate—bone cancer	0.000234	0.00142	CcSEcCtD
Azithromycin—Anaemia—Epirubicin—bone cancer	0.000234	0.00141	CcSEcCtD
Azithromycin—Agitation—Epirubicin—bone cancer	0.000232	0.00141	CcSEcCtD
Azithromycin—Flatulence—Doxorubicin—bone cancer	0.00023	0.00139	CcSEcCtD
Azithromycin—Chest pain—Methotrexate—bone cancer	0.00023	0.00139	CcSEcCtD
Azithromycin—Myalgia—Methotrexate—bone cancer	0.00023	0.00139	CcSEcCtD
Azithromycin—Arthralgia—Methotrexate—bone cancer	0.00023	0.00139	CcSEcCtD
Azithromycin—Tension—Doxorubicin—bone cancer	0.000229	0.00139	CcSEcCtD
Azithromycin—Dysgeusia—Doxorubicin—bone cancer	0.000229	0.00139	CcSEcCtD
Azithromycin—Malaise—Epirubicin—bone cancer	0.000228	0.00138	CcSEcCtD
Azithromycin—Discomfort—Methotrexate—bone cancer	0.000227	0.00138	CcSEcCtD
Azithromycin—Nervousness—Doxorubicin—bone cancer	0.000227	0.00137	CcSEcCtD
Azithromycin—Vertigo—Epirubicin—bone cancer	0.000227	0.00137	CcSEcCtD
Azithromycin—Syncope—Epirubicin—bone cancer	0.000227	0.00137	CcSEcCtD
Azithromycin—Leukopenia—Epirubicin—bone cancer	0.000226	0.00137	CcSEcCtD
Azithromycin—Palpitations—Epirubicin—bone cancer	0.000223	0.00135	CcSEcCtD
Azithromycin—Loss of consciousness—Epirubicin—bone cancer	0.000222	0.00134	CcSEcCtD
Azithromycin—Cough—Epirubicin—bone cancer	0.00022	0.00134	CcSEcCtD
Azithromycin—Anaphylactic shock—Methotrexate—bone cancer	0.00022	0.00133	CcSEcCtD
Azithromycin—Vision blurred—Doxorubicin—bone cancer	0.00022	0.00133	CcSEcCtD
Azithromycin—Convulsion—Epirubicin—bone cancer	0.000219	0.00133	CcSEcCtD
Azithromycin—Infection—Methotrexate—bone cancer	0.000219	0.00133	CcSEcCtD
Azithromycin—Hypertension—Epirubicin—bone cancer	0.000218	0.00132	CcSEcCtD
Azithromycin—Ill-defined disorder—Doxorubicin—bone cancer	0.000217	0.00131	CcSEcCtD
Azithromycin—Anaemia—Doxorubicin—bone cancer	0.000216	0.00131	CcSEcCtD
Azithromycin—Thrombocytopenia—Methotrexate—bone cancer	0.000216	0.00131	CcSEcCtD
Azithromycin—Arthralgia—Epirubicin—bone cancer	0.000215	0.0013	CcSEcCtD
Azithromycin—Chest pain—Epirubicin—bone cancer	0.000215	0.0013	CcSEcCtD
Azithromycin—Myalgia—Epirubicin—bone cancer	0.000215	0.0013	CcSEcCtD
Azithromycin—Agitation—Doxorubicin—bone cancer	0.000215	0.0013	CcSEcCtD
Azithromycin—Anxiety—Epirubicin—bone cancer	0.000214	0.0013	CcSEcCtD
Azithromycin—Hyperhidrosis—Methotrexate—bone cancer	0.000213	0.00129	CcSEcCtD
Azithromycin—Discomfort—Epirubicin—bone cancer	0.000213	0.00129	CcSEcCtD
Azithromycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000212	0.0108	CbGpPWpGaD
Azithromycin—Malaise—Doxorubicin—bone cancer	0.000211	0.00128	CcSEcCtD
Azithromycin—Dry mouth—Epirubicin—bone cancer	0.00021	0.00127	CcSEcCtD
Azithromycin—Vertigo—Doxorubicin—bone cancer	0.00021	0.00127	CcSEcCtD
Azithromycin—Anorexia—Methotrexate—bone cancer	0.00021	0.00127	CcSEcCtD
Azithromycin—Syncope—Doxorubicin—bone cancer	0.00021	0.00127	CcSEcCtD
Azithromycin—Leukopenia—Doxorubicin—bone cancer	0.000209	0.00127	CcSEcCtD
Azithromycin—Palpitations—Doxorubicin—bone cancer	0.000207	0.00125	CcSEcCtD
Azithromycin—Anaphylactic shock—Epirubicin—bone cancer	0.000206	0.00125	CcSEcCtD
Azithromycin—Oedema—Epirubicin—bone cancer	0.000206	0.00125	CcSEcCtD
Azithromycin—Hypotension—Methotrexate—bone cancer	0.000206	0.00125	CcSEcCtD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000206	0.0105	CbGpPWpGaD
Azithromycin—Loss of consciousness—Doxorubicin—bone cancer	0.000205	0.00124	CcSEcCtD
Azithromycin—Infection—Epirubicin—bone cancer	0.000205	0.00124	CcSEcCtD
Azithromycin—Cough—Doxorubicin—bone cancer	0.000204	0.00124	CcSEcCtD
Azithromycin—Shock—Epirubicin—bone cancer	0.000203	0.00123	CcSEcCtD
Azithromycin—Convulsion—Doxorubicin—bone cancer	0.000203	0.00123	CcSEcCtD
Azithromycin—Thrombocytopenia—Epirubicin—bone cancer	0.000202	0.00122	CcSEcCtD
Azithromycin—Hypertension—Doxorubicin—bone cancer	0.000202	0.00122	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000201	0.00122	CcSEcCtD
Azithromycin—Hyperhidrosis—Epirubicin—bone cancer	0.000199	0.00121	CcSEcCtD
Azithromycin—Insomnia—Methotrexate—bone cancer	0.000199	0.00121	CcSEcCtD
Azithromycin—Chest pain—Doxorubicin—bone cancer	0.000199	0.00121	CcSEcCtD
Azithromycin—Arthralgia—Doxorubicin—bone cancer	0.000199	0.00121	CcSEcCtD
Azithromycin—Myalgia—Doxorubicin—bone cancer	0.000199	0.00121	CcSEcCtD
Azithromycin—Anxiety—Doxorubicin—bone cancer	0.000198	0.0012	CcSEcCtD
Azithromycin—Paraesthesia—Methotrexate—bone cancer	0.000198	0.0012	CcSEcCtD
Azithromycin—Discomfort—Doxorubicin—bone cancer	0.000197	0.00119	CcSEcCtD
Azithromycin—Anorexia—Epirubicin—bone cancer	0.000197	0.00119	CcSEcCtD
Azithromycin—Dyspnoea—Methotrexate—bone cancer	0.000196	0.00119	CcSEcCtD
Azithromycin—Somnolence—Methotrexate—bone cancer	0.000196	0.00119	CcSEcCtD
Azithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000195	0.00998	CbGpPWpGaD
Azithromycin—Dry mouth—Doxorubicin—bone cancer	0.000195	0.00118	CcSEcCtD
Azithromycin—Dyspepsia—Methotrexate—bone cancer	0.000194	0.00117	CcSEcCtD
Azithromycin—Hypotension—Epirubicin—bone cancer	0.000193	0.00117	CcSEcCtD
Azithromycin—Decreased appetite—Methotrexate—bone cancer	0.000192	0.00116	CcSEcCtD
Azithromycin—Anaphylactic shock—Doxorubicin—bone cancer	0.000191	0.00116	CcSEcCtD
Azithromycin—Oedema—Doxorubicin—bone cancer	0.000191	0.00116	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Methotrexate—bone cancer	0.00019	0.00115	CcSEcCtD
Azithromycin—Fatigue—Methotrexate—bone cancer	0.00019	0.00115	CcSEcCtD
Azithromycin—Infection—Doxorubicin—bone cancer	0.00019	0.00115	CcSEcCtD
Azithromycin—Pain—Methotrexate—bone cancer	0.000188	0.00114	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000188	0.00114	CcSEcCtD
Azithromycin—Shock—Doxorubicin—bone cancer	0.000188	0.00114	CcSEcCtD
Azithromycin—Thrombocytopenia—Doxorubicin—bone cancer	0.000187	0.00113	CcSEcCtD
Azithromycin—Insomnia—Epirubicin—bone cancer	0.000187	0.00113	CcSEcCtD
Azithromycin—Paraesthesia—Epirubicin—bone cancer	0.000185	0.00112	CcSEcCtD
Azithromycin—Hyperhidrosis—Doxorubicin—bone cancer	0.000184	0.00112	CcSEcCtD
Azithromycin—Dyspnoea—Epirubicin—bone cancer	0.000184	0.00111	CcSEcCtD
Azithromycin—Somnolence—Epirubicin—bone cancer	0.000183	0.00111	CcSEcCtD
Azithromycin—Anorexia—Doxorubicin—bone cancer	0.000182	0.0011	CcSEcCtD
Azithromycin—Feeling abnormal—Methotrexate—bone cancer	0.000182	0.0011	CcSEcCtD
Azithromycin—Dyspepsia—Epirubicin—bone cancer	0.000182	0.0011	CcSEcCtD
Azithromycin—Gastrointestinal pain—Methotrexate—bone cancer	0.00018	0.00109	CcSEcCtD
Azithromycin—Decreased appetite—Epirubicin—bone cancer	0.000179	0.00109	CcSEcCtD
Azithromycin—Hypotension—Doxorubicin—bone cancer	0.000178	0.00108	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000178	0.00108	CcSEcCtD
Azithromycin—Fatigue—Epirubicin—bone cancer	0.000178	0.00108	CcSEcCtD
Azithromycin—Pain—Epirubicin—bone cancer	0.000176	0.00107	CcSEcCtD
Azithromycin—Constipation—Epirubicin—bone cancer	0.000176	0.00107	CcSEcCtD
Azithromycin—Urticaria—Methotrexate—bone cancer	0.000175	0.00106	CcSEcCtD
Azithromycin—Body temperature increased—Methotrexate—bone cancer	0.000174	0.00105	CcSEcCtD
Azithromycin—Abdominal pain—Methotrexate—bone cancer	0.000174	0.00105	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000174	0.00105	CcSEcCtD
Azithromycin—Insomnia—Doxorubicin—bone cancer	0.000173	0.00104	CcSEcCtD
Azithromycin—Paraesthesia—Doxorubicin—bone cancer	0.000171	0.00104	CcSEcCtD
Azithromycin—Dyspnoea—Doxorubicin—bone cancer	0.00017	0.00103	CcSEcCtD
Azithromycin—Feeling abnormal—Epirubicin—bone cancer	0.00017	0.00103	CcSEcCtD
Azithromycin—Somnolence—Doxorubicin—bone cancer	0.00017	0.00103	CcSEcCtD
Azithromycin—Gastrointestinal pain—Epirubicin—bone cancer	0.000169	0.00102	CcSEcCtD
Azithromycin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000168	0.00861	CbGpPWpGaD
Azithromycin—Dyspepsia—Doxorubicin—bone cancer	0.000168	0.00102	CcSEcCtD
Azithromycin—Decreased appetite—Doxorubicin—bone cancer	0.000166	0.001	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000165	0.000997	CcSEcCtD
Azithromycin—Fatigue—Doxorubicin—bone cancer	0.000164	0.000996	CcSEcCtD
Azithromycin—Urticaria—Epirubicin—bone cancer	0.000164	0.000992	CcSEcCtD
Azithromycin—Pain—Doxorubicin—bone cancer	0.000163	0.000988	CcSEcCtD
Azithromycin—Constipation—Doxorubicin—bone cancer	0.000163	0.000988	CcSEcCtD
Azithromycin—Abdominal pain—Epirubicin—bone cancer	0.000163	0.000987	CcSEcCtD
Azithromycin—Body temperature increased—Epirubicin—bone cancer	0.000163	0.000987	CcSEcCtD
Azithromycin—Hypersensitivity—Methotrexate—bone cancer	0.000162	0.000983	CcSEcCtD
Azithromycin—Asthenia—Methotrexate—bone cancer	0.000158	0.000957	CcSEcCtD
Azithromycin—Feeling abnormal—Doxorubicin—bone cancer	0.000157	0.000952	CcSEcCtD
Azithromycin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000156	0.000945	CcSEcCtD
Azithromycin—Pruritus—Methotrexate—bone cancer	0.000156	0.000944	CcSEcCtD
Azithromycin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000153	0.00784	CbGpPWpGaD
Azithromycin—Hypersensitivity—Epirubicin—bone cancer	0.000152	0.00092	CcSEcCtD
Azithromycin—Urticaria—Doxorubicin—bone cancer	0.000152	0.000918	CcSEcCtD
Azithromycin—Abdominal pain—Doxorubicin—bone cancer	0.000151	0.000913	CcSEcCtD
Azithromycin—Body temperature increased—Doxorubicin—bone cancer	0.000151	0.000913	CcSEcCtD
Azithromycin—Diarrhoea—Methotrexate—bone cancer	0.000151	0.000913	CcSEcCtD
Azithromycin—Asthenia—Epirubicin—bone cancer	0.000148	0.000896	CcSEcCtD
Azithromycin—Pruritus—Epirubicin—bone cancer	0.000146	0.000883	CcSEcCtD
Azithromycin—Dizziness—Methotrexate—bone cancer	0.000146	0.000882	CcSEcCtD
Azithromycin—Diarrhoea—Epirubicin—bone cancer	0.000141	0.000854	CcSEcCtD
Azithromycin—Hypersensitivity—Doxorubicin—bone cancer	0.000141	0.000851	CcSEcCtD
Azithromycin—Vomiting—Methotrexate—bone cancer	0.00014	0.000848	CcSEcCtD
Azithromycin—Rash—Methotrexate—bone cancer	0.000139	0.000841	CcSEcCtD
Azithromycin—Dermatitis—Methotrexate—bone cancer	0.000139	0.00084	CcSEcCtD
Azithromycin—Headache—Methotrexate—bone cancer	0.000138	0.000836	CcSEcCtD
Azithromycin—Asthenia—Doxorubicin—bone cancer	0.000137	0.000829	CcSEcCtD
Azithromycin—Dizziness—Epirubicin—bone cancer	0.000136	0.000826	CcSEcCtD
Azithromycin—Pruritus—Doxorubicin—bone cancer	0.000135	0.000817	CcSEcCtD
Azithromycin—Vomiting—Epirubicin—bone cancer	0.000131	0.000794	CcSEcCtD
Azithromycin—Nausea—Methotrexate—bone cancer	0.000131	0.000793	CcSEcCtD
Azithromycin—Diarrhoea—Doxorubicin—bone cancer	0.000131	0.00079	CcSEcCtD
Azithromycin—Rash—Epirubicin—bone cancer	0.00013	0.000787	CcSEcCtD
Azithromycin—Dermatitis—Epirubicin—bone cancer	0.00013	0.000787	CcSEcCtD
Azithromycin—Headache—Epirubicin—bone cancer	0.000129	0.000782	CcSEcCtD
Azithromycin—Dizziness—Doxorubicin—bone cancer	0.000126	0.000764	CcSEcCtD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000124	0.00634	CbGpPWpGaD
Azithromycin—Nausea—Epirubicin—bone cancer	0.000122	0.000742	CcSEcCtD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000122	0.00626	CbGpPWpGaD
Azithromycin—Vomiting—Doxorubicin—bone cancer	0.000121	0.000735	CcSEcCtD
Azithromycin—Rash—Doxorubicin—bone cancer	0.00012	0.000728	CcSEcCtD
Azithromycin—Dermatitis—Doxorubicin—bone cancer	0.00012	0.000728	CcSEcCtD
Azithromycin—Headache—Doxorubicin—bone cancer	0.00012	0.000724	CcSEcCtD
Azithromycin—Nausea—Doxorubicin—bone cancer	0.000113	0.000686	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000112	0.00575	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000111	0.00568	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.00011	0.0056	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.00011	0.0056	CbGpPWpGaD
Azithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000107	0.00545	CbGpPWpGaD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000101	0.00514	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—GSTP1—bone cancer	9.61e-05	0.00491	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	8.72e-05	0.00446	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.27e-05	0.00423	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	7.81e-05	0.00399	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.42e-05	0.00379	CbGpPWpGaD
Azithromycin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.05e-05	0.0036	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	6.8e-05	0.00347	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	6.75e-05	0.00345	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NDUFA12—bone cancer	6.74e-05	0.00344	CbGpPWpGaD
Azithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.36e-05	0.00325	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.15e-05	0.00314	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.13e-05	0.00313	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.07e-05	0.0031	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	5.75e-05	0.00294	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NT5C3A—bone cancer	5.58e-05	0.00285	CbGpPWpGaD
Azithromycin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.44e-05	0.00278	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.34e-05	0.00273	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.27e-05	0.00269	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.14e-05	0.00263	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.13e-05	0.00262	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.82e-05	0.00246	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.82e-05	0.00246	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.57e-05	0.00233	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.5e-05	0.0023	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.43e-05	0.00226	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NDUFA12—bone cancer	4.01e-05	0.00205	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.81e-05	0.00195	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.52e-05	0.0018	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.48e-05	0.00178	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NT5C3A—bone cancer	3.32e-05	0.0017	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NDUFA12—bone cancer	3.2e-05	0.00164	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.83e-05	0.00145	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.73e-05	0.00139	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NT5C3A—bone cancer	2.65e-05	0.00136	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NDUFA12—bone cancer	2.47e-05	0.00126	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.46e-05	0.00126	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ENO2—bone cancer	2.45e-05	0.00125	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—DHFR—bone cancer	2.27e-05	0.00116	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GNA11—bone cancer	2.12e-05	0.00108	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NT5C3A—bone cancer	2.05e-05	0.00105	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.93e-05	0.000988	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP3A4—bone cancer	1.92e-05	0.000983	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTP1—bone cancer	1.64e-05	0.00084	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.62e-05	0.000829	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ENO2—bone cancer	1.46e-05	0.000744	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—DHFR—bone cancer	1.35e-05	0.00069	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GNA11—bone cancer	1.26e-05	0.000645	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ENO2—bone cancer	1.16e-05	0.000594	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP3A4—bone cancer	1.14e-05	0.000585	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—DHFR—bone cancer	1.08e-05	0.000551	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GNA11—bone cancer	1.01e-05	0.000515	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTP1—bone cancer	9.78e-06	0.0005	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP3A4—bone cancer	9.13e-06	0.000467	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.09e-06	0.000464	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ENO2—bone cancer	8.97e-06	0.000458	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PTGS2—bone cancer	8.52e-06	0.000435	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—DHFR—bone cancer	8.32e-06	0.000425	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTP1—bone cancer	7.81e-06	0.000399	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GNA11—bone cancer	7.77e-06	0.000397	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTP1—bone cancer	6.03e-06	0.000308	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PTGS2—bone cancer	5.07e-06	0.000259	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PTGS2—bone cancer	4.05e-06	0.000207	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PTGS2—bone cancer	3.12e-06	0.00016	CbGpPWpGaD
